Wednesday, May 25, 2016

BRIEF-Roche Holding announces FDA-approved test for use in hematopoietic stem cell transplant recipients

* Roche announces first fda-approved cmv test for use in

hematopoietic stem cell transplant recipients

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +91 806 749 1136)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)